24671324|t|Necrotising fasciitis after bortezomib and dexamethasone-containing regimen in an elderly patient of Waldenstrom macroglobulinaemia.
24671324|a|Bortezomib and high-dose dexamethasone-containing regimens are considered to be generally tolerable with few severe bacterial infections in patients with B-cell malignancies. However, information is limited concerning the safety of the regimen in elderly patients. We report a case of a 76-year-old man with Waldenstrom macroglobulinaemia who suffered necrotising fasciitis without neutropenia after the combination treatment with bortezomib, high-dose dexamethasone and rituximab. Despite immediate intravenous antimicrobial therapy, he succumbed 23 h after the onset. Physicians should recognise the possibility of fatal bacterial infections related to bortezomib plus high-dose dexamethasone in elderly patients, and we believe this case warrants further investigation.
24671324	0	21	Necrotising fasciitis	DiseaseOrPhenotypicFeature	D019115
24671324	28	38	bortezomib	ChemicalEntity	D000069286
24671324	43	56	dexamethasone	ChemicalEntity	D003907
24671324	90	97	patient	OrganismTaxon	9606
24671324	101	131	Waldenstrom macroglobulinaemia	DiseaseOrPhenotypicFeature	D008258
24671324	133	143	Bortezomib	ChemicalEntity	D000069286
24671324	158	171	dexamethasone	ChemicalEntity	D003907
24671324	249	269	bacterial infections	DiseaseOrPhenotypicFeature	D001424
24671324	273	281	patients	OrganismTaxon	9606
24671324	294	306	malignancies	DiseaseOrPhenotypicFeature	D009369
24671324	388	396	patients	OrganismTaxon	9606
24671324	432	435	man	OrganismTaxon	9606
24671324	441	471	Waldenstrom macroglobulinaemia	DiseaseOrPhenotypicFeature	D008258
24671324	485	506	necrotising fasciitis	DiseaseOrPhenotypicFeature	D019115
24671324	515	526	neutropenia	DiseaseOrPhenotypicFeature	D009503
24671324	564	574	bortezomib	ChemicalEntity	D000069286
24671324	586	599	dexamethasone	ChemicalEntity	D003907
24671324	604	613	rituximab	ChemicalEntity	D000069283
24671324	756	776	bacterial infections	DiseaseOrPhenotypicFeature	D001424
24671324	788	798	bortezomib	ChemicalEntity	D000069286
24671324	814	827	dexamethasone	ChemicalEntity	D003907
24671324	839	847	patients	OrganismTaxon	9606
24671324	Positive_Correlation	D001424	D003907	Novel
24671324	Positive_Correlation	D001424	D000069286	Novel
24671324	Negative_Correlation	D000069283	D008258	No
24671324	Negative_Correlation	D003907	D009369	No
24671324	Cotreatment	D003907	D000069283	No
24671324	Negative_Correlation	D003907	D008258	No
24671324	Negative_Correlation	D000069286	D009369	No
24671324	Cotreatment	D000069286	D000069283	No
24671324	Negative_Correlation	D000069286	D008258	No
24671324	Cotreatment	D000069286	D003907	No
24671324	Positive_Correlation	D019115	D003907	Novel
24671324	Positive_Correlation	D019115	D000069286	Novel